Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism.
Lang
J E
JE
Cholesterol Center, Jewish Hospital, Cincinnati, Ohio 45229, USA.
Wang
P
P
Glueck
C J
CJ
D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use; D005260:Female; D000077340:Fluvastatin; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007037:Hypothyroidism / Q000150:complications* / Q000188:drug therapy; D007211:Indoles / Q000627:therapeutic use; D008148:Lovastatin / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009468:Neuromuscular Diseases / Q000150:complications* / Q000188:drug therapy; D019821:Simvastatin; D013974:Thyroxine / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D005229:Fatty Acids, Monounsaturated; D000960:Hypolipidemic Agents; D007211:Indoles; D000077340:Fluvastatin; D008148:Lovastatin; D019821:Simvastatin; D013974:Thyroxine; D015248:Gemfibrozil